Clinical Trial Update: A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of tislelizumab in combination with investigational agents for head and neck squamous cell carcinoma; the trial is currently active but not recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Tislelizumab (tislelizumab)

Snippet

Sponsor: BeiGene | Conditions: Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING